Skip to content

Clinical trials

Phase 2 Corneal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Corneal Diseases Phase: Phase 2 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20091
20112
20121
20141
20161
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Enrolling by invitation1
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kissei Pharmaceutical Co., Ltd.5
Alcon Research1
Cxlusa1
Glaukos Corporation1
Henry M. Jackson Foundation for the Advancement of Military Medicine1
Isfahan University of Medical Sciences1
Medical University of Vienna1
Mercy Center for Corrective Eye Surgery1
National Eye Institute (NEI)1
OcuNexus Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Corneal Diseases16
Dry Eye Syndromes7
Conjunctival Diseases5
Keratoconus4
Eye Diseases3
Blepharitis1
Conjunctivitis1
Corneal Neovascularization1
Corneal Ulcer1
Cowpox1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.